Cardiff Oncology Inc
CRDF2.920USD
+0.350+13.62%
Close 12/22, 16:00（ET）Quotes delayed by 15 min
195.92MMarket Cap
LossP/E TTM
Cardiff Oncology Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
683.00K
39.96%
EPS(YoY)
-0.95
-2.78%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Cardiff Oncology Inc?
According to Cardiff Oncology Inc's FY2024 earnings report, its total revenue reached 683.00K, with a year-on-year change of 39.96%.
What is the Earnings Per Share (EPS) of Cardiff Oncology Inc?
According to Cardiff Oncology Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -0.954, with a year-on-year change of -2.78%.
What is the net income of Cardiff Oncology Inc?
According to Cardiff Oncology Inc's FY2024 earnings report, its net income was -45.45M, with a year-on-year change of -9.62%.
What is the net margin of Cardiff Oncology Inc?
According to Cardiff Oncology Inc's FY2024 earnings report, its net profit margin was -6651.68%, with a year-on-year change of 21.67%.
What is the gross margin of Cardiff Oncology Inc?
According to Cardiff Oncology Inc's FY2024 earnings report, its gross margin was 100.00%, with a year-on-year change of --.
What is the debt-to-asset ratio of Cardiff Oncology Inc?
According to Cardiff Oncology Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Cardiff Oncology Inc?
According to Cardiff Oncology Inc's FY2024 earnings report, its Return on Equity (ROE) was -59.54%, with a year-on-year change of -26.42%.
What is the Return on Assets (ROA) of Cardiff Oncology Inc?
According to Cardiff Oncology Inc's FY2024 earnings report, its Return on Assets (ROA) was -50.81%, with a year-on-year change of -21.28%.
What is the operating profit of Cardiff Oncology Inc?
According to Cardiff Oncology Inc's FY2024 earnings report, its operating profit was -48.65M, with a year-on-year change of -7.13%.
What are the current assets of Cardiff Oncology Inc?
According to Cardiff Oncology Inc's FY2024 earnings report, its current assets were 95.05M, with a year-on-year change of 22.79%.
What are the total assets of Cardiff Oncology Inc?
According to Cardiff Oncology Inc's FY2024 earnings report, its total assets of Cardiff Oncology Inc were 97.19M, with a year-on-year change of 19.05%.
What are the total liabilities of Cardiff Oncology Inc?
According to Cardiff Oncology Inc's FY2024 earnings report, its total liabilities of Cardiff Oncology Inc were 14.24M, with a year-on-year change of 19.69%.
What is the total equity of Cardiff Oncology Inc?
According to Cardiff Oncology Inc's FY2024 earnings report, its total equity of Cardiff Oncology Inc was 82.95M, with a year-on-year change of 18.94%.
What is the net operating income of Cardiff Oncology Inc?
According to Cardiff Oncology Inc's FY2024 earnings report, its net operating income of Cardiff Oncology Inc was -45.43M, with a year-on-year change of -9.63%.
What is the net investment of Cardiff Oncology Inc?
According to Cardiff Oncology Inc's FY2024 earnings report, its net investment of Cardiff Oncology Inc was 13.73M, with a year-on-year change of -62.07%.
What is the net financing of Cardiff Oncology Inc?
According to Cardiff Oncology Inc's FY2024 earnings report, its net financing of Cardiff Oncology Inc was 53.78M, with a year-on-year change of --.
